If India doesn't release anti-malaria drug, there will be retaliation, says Trump

If India doesn't release anti-malaria drug, there will be retaliation, says Trump

US President Donald Trump has said that if India does not allow export of anti-malaria drug Hydroxychloroquine to the US, as requested, there may be retaliation.

Last week Trump said that he has sought help from Prime Minister Narendra Modi to allow the sale of Hydroxychloroquine tablets ordered by the US to treat the growing number of coronavirus patients in his country, hours after India banned the export of the anti-malarial drug.

He has said he would be surprised if India did not allow the export of Hydroxychloroquine tablets to the United States.

"So, I would be surprised if that were his decision. He'd have to tell me that. I spoke to him Sunday morning, called him, and I said we'd appreciate your allowing our supply to come out. If he doesn't allow it to come out, that would be okay, but of course, there may be retaliation. Why wouldn't there be?" Trump said.

"I would be surprised if he would, you know, because India does very well with the United States," Trump told reporters during a press briefing at the White House on Monday.

Hydroxychloroquine tablet is used to prevent and treat malaria, lupus and rheumatoid arthritis, among other ailments.

The drug is seen as to offer a viable therapeutic solution to coronavirus that has so far taken the lives of more than 10,000 Americans and infected over 3.6 lakhs, just in a matter of weeks.

Last month, India imposed a ban on export on Hydroxychloroquine, on which Trump is now banking heavily in the treatment of Covid-19 patients.

India has received similar requests from several other countries including its immediate neighbours like Sri Lanka and Nepal. India has said that it is reviewing its export ban order.